EPIVAL
BGP PHARMA ULC
Quick answers
Is there a shortage of EPIVAL in Canada?
No. There is no current shortage of EPIVAL 500MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
DEPAKENE CAP 500MG
ABBOTT LABORATORIES, LIMITED
SANDOZ VALPROIC
SANDOZ CANADA INCORPORATED
RATIO-VALPROIC - ECC 500MG
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
EPIVAL
BGP PHARMA ULC
MYLAN-VALPROIC
MYLAN PHARMACEUTICALS ULC
NOVO-VALPROIC
TEVA CANADA LIMITED
DIN
00596434
Strength
500MG
Dosage Form
TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED)
Route
ORAL
Compare with another product →
Shortage History
Disruption of the manufacture of the drug.
Shortage of an active ingredient.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.